Skip to content

Survey on cognitive function scales for major depressive disorder in Japan

Survey on cognitive function scales for major depressive disorder in Japan - Survey on cognitive function scales for major depressive disorder in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000055874
Enrollment
30
Registered
2024-11-01
Start date
2024-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder (MDD)

Interventions

None listed

Sponsors

Takeda Pharmaceutical Company Limited.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Experience with at least one of the cognitive function scales targeted in this study. Psychiatrists.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Identify the characteristics of each targeted cognitive function scale. Participant will rate the following perspectives on a scale of 1-5. (difficulty of introducing a new routine clinical practice / knowledge and experience required for accurate evaluation / time required from explanation to completion / difficulty of result calculation / knowledge and experience required for effective utilization of results)

Secondary

MeasureTime frame
Estimate the usage rate of each cognitive function scale. Participants will answer whether they had experience using each rating scale.

Countries

Japan

Contacts

Public ContactFumie Tokuda

Takeda Pharmaceutical Company Limited. Japan Medical Office

fumie.tokuda@takeda.com03-3242-1256

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026